(Q21245401)

ORCID Public Data File 2021

Dimensions Publication ID

Dimensions

16 August 2022

Jill E Emerick

1

Jill E

Emerick

1 reference

Dimensions Publication ID

Dimensions

1028156867

International journal of pediatric endocrinology

16 August 2022

language of work or name

English

0 references

publication date

2013

0 references

published in

1 reference

Creative Commons Attribution 2.0 Generic

volume

2013

0 references

issue

1

0 references

page(s)

14

0 references

copyright license

start time

21 August 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

exact match

https://scigraph.springernature.com/pub.10.1186/1687-9856-2013-14

0 references

cites work

Neural mechanisms underlying hyperphagia in Prader-Willi syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751775

Decreased bone mineral density in Prader-Willi syndrome: comparison with obese subjects

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751775

GrowthHormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751775

Approach to the child with prader-willi syndrome

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751775

A reduced-energy intake, well-balanced diet improves weight control in children with Prader-Willi syndrome

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751775

Effects of recombinant human growth hormone therapy in adults with Prader-Willi syndrome: a meta-analysis

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751775

Growth hormone treatment in adults with Prader-Willi syndrome: the Scandinavian study

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751775

The metabolic phenotype of Prader-Willi syndrome (PWS) in childhood: heightened insulin sensitivity relative to body mass index

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751775

Endocrine disorders in children with Prader-Willi syndrome--data from 142 children of the French database

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751775

Long-term growth hormone therapy changes the natural history of body composition and motor function in children with prader-willi syndrome

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751775

Efficacy and safety of long-term continuous growth hormone treatment in children with Prader-Willi syndrome

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751775

Randomized controlled trial to investigate the effects of growth hormone treatment on scoliosis in children with Prader-Willi syndrome

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751775

Recommendations for the diagnosis and management of Prader-Willi syndrome

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751775

Sleepiness and sleep disordered breathing in Prader-Willi syndrome: relationship to genotype, growth hormone therapy, and body composition

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751775

Enhanced activation of reward mediating prefrontal regions in response to food stimuli in Prader-Willi syndrome

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751775

Satiety dysfunction in Prader-Willi syndrome demonstrated by fMRI.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751775

Hypogonadism and pubertal development in Prader-Willi syndrome.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751775

Sleep and breathing in Prader-Willi syndrome

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751775

Benefits of long-term GH therapy in Prader-Willi syndrome: a 4-year study

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751775

Endocrine dysfunction in Prader-Willi syndrome: a review with special reference to GH.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751775

Eating behavior in Prader-Willi syndrome, normal weight, and obese control groups

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751775

Abnormal ventilatory responses in patients with Prader-Willi syndrome

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751775

Long-acting octreotide treatment causes a sustained decrease in ghrelin concentrations but does not affect weight, behaviour and appetite in subjects with Prader-Willi syndrome.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751775

Intraoperative adrenal insufficiency in a patient with prader-willi syndrome

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751775

Growth hormone secretion among adult patients with Prader-Willi syndrome due to different genetic subtypes

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751775

Successful early dietary intervention avoids obesity in patients with Prader-Willi syndrome: a ten-year follow-up.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751775

Characterization of alterations in carbohydrate metabolism in children with Prader-Willi syndrome.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751775

Somatostatin infusion lowers plasma ghrelin without reducing appetite in adults with Prader-Willi syndrome

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751775

Respiratory control in children with Prader-Willi syndrome.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751775

30 May 2018

Prader-Willi syndrome.

1 reference

https://api.crossref.org/works/10.1186%2F1687-9856-2013-14

Nutritional phases in Prader-Willi syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1687-9856-2013-14

Serum ghrelin levels are inversely correlated with body mass index, age, and insulin concentrations in normal children and are markedly increased in Prader-Willi syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1687-9856-2013-14

Energy expenditure and physical activity in Prader-Willi syndrome: comparison with obese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1687-9856-2013-14

Decreased energy expenditure is caused by abnormal body composition in infants with Prader-Willi Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1687-9856-2013-14

Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader-Willi syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1687-9856-2013-14

Mental and motor development before and during growth hormone treatment in infants and toddlers with Prader-Willi syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1687-9856-2013-14

Two years of growth hormone therapy in young children with Prader-Willi syndrome: physical and neurodevelopmental benefits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1687-9856-2013-14

Long-term effects of growth hormone therapy on patients with Prader-Willi syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1687-9856-2013-14

The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1687-9856-2013-14

Effects of growth hormone on pulmonary function, sleep quality, behavior, cognition, growth velocity, body composition, and resting energy expenditure in Prader-Willi syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1687-9856-2013-14

Growth hormone therapy for children and adolescents with Prader-Willi syndrome is associated with improved body composition and metabolic status in adulthood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1687-9856-2013-14

Growth hormone treatment of adults with Prader-Willi syndrome and growth hormone deficiency improves lean body mass, fractional body fat, and serum triiodothyronine without glucose impairment: results from the United States multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1687-9856-2013-14

Short-term effects of growth hormone on sleep abnormalities in Prader-Willi syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1687-9856-2013-14

Longitudinal association between growth hormone therapy and obstructive sleep apnea in a child with Prader-Willi syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1687-9856-2013-14

Scoliosis in patients with Prader-Willi Syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1687-9856-2013-14

High prevalence of central adrenal insufficiency in patients with Prader-Willi syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1687-9856-2013-14

Central adrenal insufficiency in young adults with Prader-Willi syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1687-9856-2013-14

Adrenal function and mortality in children and adolescents with Prader-Willi syndrome attending a single centre from 1991-2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1687-9856-2013-14

Normal cortisol response on low-dose synacthen (1 microg) test in children with Prader Willi syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1687-9856-2013-14

Normal cortisol response to high-dose synacthen and insulin tolerance test in children and adults with Prader-Willi syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1687-9856-2013-14

Multiple forms of hypogonadism of central, peripheral or combined origin in males with Prader-Willi syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1687-9856-2013-14

Hypothalamic and gonadal components of hypogonadism in boys with Prader-Labhart- Willi syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1687-9856-2013-14

Ovarian function and reproductive hormone levels in girls with Prader-Willi syndrome: a longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1687-9856-2013-14

Reduced bone mineral density and increased bone turnover in Prader-Willi syndrome compared with controls matched for sex and body mass index--a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1687-9856-2013-14

Prevalence of, and risk factors for, physical ill-health in people with Prader-Willi syndrome: a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1687-9856-2013-14

Low insulin, IGF-I and IGFBP-3 levels in children with Prader-Labhart-Willi syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1687-9856-2013-14

Insulin resistance and obesity-related factors in Prader-Willi syndrome: comparison with obese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1687-9856-2013-14

Assessment of central adrenal insufficiency in children and adolescents with Prader-Willi syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1687-9856-2013-14

Thyroid axis dysfunction in patients with Prader-Willi syndrome during the first 2 years of life

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751775

A daily comprehensive muscle training programme increases lean mass and spontaneous activity in children with Prader-Willi syndrome after 6 months

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751775

Growth hormone and body composition in children younger than 2 years with Prader-Willi syndrome.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751775

Fertility in Prader-Willi syndrome: a case report with Angelman syndrome in the offspring.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3751775

Characteristics of the eating disorder in Prader-Willi syndrome: implications for treatment

29 November 2018

1 reference

12 December 2020

'A woman with Prader-Willi syndrome gives birth to a healthy baby girl'

1 reference

12 December 2020

Testicular failure in boys with Prader-Willi syndrome: longitudinal studies of reproductive hormones

1 reference

12 December 2020

Beneficial effects of growth hormone treatment on cognition in children with Prader-Willi syndrome: a randomized controlled trial and longitudinal study

1 reference

12 December 2020

Premature adrenarche, increased growth velocity and accelerated bone age in male patients with Prader-Labhart-Willi syndrome

1 reference

12 December 2020

Clinical report—health supervision for children with Prader-Willi syndrome

1 reference

12 December 2020

Unexpected death and critical illness in Prader-Willi syndrome: report of ten individuals

1 reference

12 December 2020

Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome

1 reference

12 December 2020

Body fat determined by skinfold measurements is elevated despite underweight in infants with Prader-Labhart-Willi syndrome

1 reference

12 December 2020

Elevated insulin-like growth factor-I values in children with Prader-Willi syndrome compared with growth hormone (GH) deficiency children over two years of GH treatment

1 reference

12 December 2020

Thyroid function studies in Prader-Willi syndrome

1 reference

12 December 2020

Is scoliosis an issue for giving growth hormone to children with Prader-Willi syndrome?

1 reference

12 December 2020

Growth hormone treatment of children with Prader-Willi syndrome affects linear growth and body composition favourably

1 reference

12 December 2020

Scoliosis in Prader-Willi syndrome: prevalence, effects of age, gender, body mass index, lean body mass and genotype

1 reference

12 December 2020

Bone mineral density and effects of growth hormone treatment in prepubertal children with Prader-Willi syndrome: a randomized controlled trial

1 reference

12 December 2020

Pituitary abnormalities in Prader-Willi syndrome and early onset morbid obesity

1 reference

12 December 2020

Testicular histology in boys with Prader-Willi syndrome: fertile or infertile?

1 reference

12 December 2020

Thyroid hormone levels in children with Prader-Willi syndrome before and during growth hormone treatment

1 reference

12 December 2020

Review of 64 cases of death in children with Prader-Willi syndrome (PWS)

1 reference

12 December 2020

Growth hormone improves mobility and body composition in infants and toddlers with Prader-Willi syndrome

1 reference

12 December 2020

Hyperghrelinemia precedes obesity in Prader-Willi syndrome

1 reference

12 December 2020

Two years of growth hormone treatment in adults with Prader-Willi syndrome do not improve the low BMD

1 reference

12 December 2020

Growth hormone improves body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome: A controlled study

1 reference

12 December 2020

Pubarche and serum dehydroepiandrosterone sulphate levels in children with Prader-Willi syndrome

1 reference

12 December 2020

10.1186/1687-9856-2013-14

Identifiers

DOI

1 reference

Dimensions Publication ID

526257

1028156867

0 references

526257

1 reference

1 reference

1 reference